EPIDERMOLYSIS BULLOSA (EB)
Clinical trials for EPIDERMOLYSIS BULLOSA (EB) explained in plain language.
Never miss a new study
Get alerted when new EPIDERMOLYSIS BULLOSA (EB) trials appear
Sign up with your email to follow new studies for EPIDERMOLYSIS BULLOSA (EB), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to heal wounds in rare blistering skin disorders
Disease control Not yet recruitingThis early-phase study tests whether the drug efgartigimod (VYVGART) can lower levels of harmful antibodies that attack collagen VII, a key skin protein, in people with two rare blistering diseases: recessive dystrophic epidermolysis bullosa (RDEB) and epidermolysis bullosa acqui…
Matched conditions: EPIDERMOLYSIS BULLOSA (EB)
Phase: PHASE1, PHASE2 • Sponsor: M. Peter Marinkovich • Aim: Disease control
Last updated May 17, 2026 11:53 UTC
-
Oxygen chamber study targets dozens of diseases from long COVID to frostbite
Disease control Not yet recruitingThis study will test hyperbaric oxygen therapy (HBOT) in 100 people with various conditions, including long COVID, Crohn's disease, frostbite, and more. HBOT involves breathing pure oxygen in a pressurized chamber to help the body heal. The goal is to see if HBOT improves quality…
Matched conditions: EPIDERMOLYSIS BULLOSA (EB)
Phase: PHASE4 • Sponsor: Jay C. Buckey Jr. • Aim: Disease control
Last updated May 17, 2026 11:38 UTC
-
New cream aims to safely treat rare skin disease
Disease control Not yet recruitingThis study is testing the safety of a cream called SD-101 for people with epidermolysis bullosa (EB), a condition that causes fragile, blistering skin. About 80 participants who completed a prior study will apply the cream and be monitored for side effects. The goal is to see if …
Matched conditions: EPIDERMOLYSIS BULLOSA (EB)
Phase: PHASE3 • Sponsor: Paradigm Therapeutics • Aim: Disease control
Last updated May 13, 2026 15:58 UTC
-
New cream could speed wound healing for kids with butterfly skin
Disease control Not yet recruitingThis study tests a cream called SD-101 on children aged 1 month to 12 years with epidermolysis bullosa (EB), a condition causing fragile skin and painful blisters. The cream is applied to the whole body to see if it helps close a target wound within one month. About 80 children w…
Matched conditions: EPIDERMOLYSIS BULLOSA (EB)
Phase: PHASE3 • Sponsor: Paradigm Therapeutics • Aim: Disease control
Last updated May 04, 2026 16:23 UTC